Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B viral resistance: mechanisms and diagnosis.

Literature DB >> 14708690

Hepatitis B viral resistance: mechanisms and diagnosis.

Stephen Locarnini¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 14708690 DOI： 10.1016/s0168-8278(03)00318-0

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Viral quasispecies evolution.

Authors: Esteban Domingo; Julie Sheldon; Celia Perales
Journal: Microbiol Mol Biol Rev Date: 2012-06 Impact factor: 11.056

2. A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.

Authors: J Shang; H Wang; J Sun; Z Fan; F Huang; Y Zhang; Q Jiang; M Dai; N Xu; R Lin; Q Liu
Journal: Bone Marrow Transplant Date: 2016-01-11 Impact factor: 5.483

3. [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors: Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal: Wien Klin Wochenschr Date: 2010-05-04 Impact factor: 1.704

4. New insights into the evolutionary rate of hepatitis B virus at different biological scales.

Authors: You-Yu Lin; Chieh Liu; Wei-Hung Chien; Li-Ling Wu; Yong Tao; Dafei Wu; Xuemei Lu; Chia-Hung Hsieh; Pei-Jer Chen; Hurng-Yi Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal: J Virol Date: 2015-01-14 Impact factor: 5.103

5. Molecular evolution of hepatitis B virus over 25 years.

Authors: Carla Osiowy; Elizabeth Giles; Yasuhito Tanaka; Masashi Mizokami; Gerald Y Minuk
Journal: J Virol Date: 2006-11 Impact factor: 5.103

6. Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors: Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal: BMC Infect Dis Date: 2011-11-04 Impact factor: 3.090

Hepatitis B viral resistance: mechanisms and diagnosis.

Review 1. Viral quasispecies evolution.

2. A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.

3. [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

4. New insights into the evolutionary rate of hepatitis B virus at different biological scales.

5. Molecular evolution of hepatitis B virus over 25 years.

6. Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

7. Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.

8. Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome.

9. Understanding the molecular basis of HBV drug resistance by molecular modeling.

Review 10. Natural products as promising drug candidates for the treatment of hepatitis B and C.